<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>JAMA: Surgery Topic Collection</title>
    <link>http://jama.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Wed, 19 Jun 2013 00:00:00 GMT</pubDate>
    <lastBuildDate>Tue, 18 Jun 2013 20:47:19 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@jama.jamanetwork.com</managingEditor>
    <webMaster>webmaster@jama.jamanetwork.com</webMaster>
    <item>
      <title>The Boston Marathon Response Why Did It Work So Well? </title>
      <link>http://jama.jamanetwork.com/article.aspx?articleID=1684255</link>
      <pubDate>Wed, 19 Jun 2013 00:00:00 GMT</pubDate>
      <author>Walls RM, Zinner MJ. </author>
      <description>&lt;span class="paragraphSection"&gt;On Monday, April 15, 2013, Boston emergency medical services and other agencies transported scores of casualties to local hospitals within 90 minutes of the 2 explosions at 2:50 PM near the Boylston Street finish line of the 117th Boston Marathon. Brigham and Women's Hospital received 39 casualties overall, 31 on Monday, and 23 of these in the first hour. Many of these patients had severe injuries, including penetrating head and neck injuries and exsanguinating orthopedic blast injuries. Other trauma centers in the area received similar patients in similar numbers. Overall, only 3 people were killed by these explosive devices, and all 3 died before reaching the hospital. Not one patient who arrived at a hospital subsequently died. How did this happen?&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">309</prism:volume>
      <prism:number xmlns:prism="prism">23</prism:number>
      <prism:startingPage xmlns:prism="prism">2441</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">2442</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/jama.2013.5965</prism:doi>
      <guid>http://jama.jamanetwork.com/article.aspx?articleID=1684255</guid>
    </item>
    <item>
      <title>Endosonography vs Conventional Bronchoscopy for the Diagnosis of Sarcoidosis The GRANULOMA Randomized Clinical Trial  Endosonography vs Bronchoscopy for Diagnosis of Sarcoidosis </title>
      <link>http://jama.jamanetwork.com/article.aspx?articleID=1697962</link>
      <pubDate>Wed, 19 Jun 2013 00:00:00 GMT</pubDate>
      <author>von Bartheld MB, Dekkers OM, Szlubowski A, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;&lt;div class="boxTitle"&gt;Importance&lt;/div&gt;Tissue verification of noncaseating granulomas is recommended for the diagnosis of sarcoidosis. Bronchoscopy with transbronchial lung biopsies, the current diagnostic standard, has moderate sensitivity in assessing granulomas. Endosonography with intrathoracic nodal aspiration appears to be a promising diagnostic technique.&lt;div class="boxTitle"&gt;Objective&lt;/div&gt;To evaluate the diagnostic yield of bronchoscopy vs endosonography in the diagnosis of stage I/II sarcoidosis.&lt;div class="boxTitle"&gt;Design, Setting, and Patients&lt;/div&gt;Randomized clinical multicenter trial (14 centers in 6 countries) between March 2009 and November 2011 of 304 consecutive patients with suspected pulmonary sarcoidosis (stage I/II) in whom tissue confirmation of noncaseating granulomas was indicated.&lt;div class="boxTitle"&gt;Interventions&lt;/div&gt;Either bronchoscopy with transbronchial and endobronchial lung biopsies or endosonography (esophageal or endobronchial ultrasonography) with aspiration of intrathoracic lymph nodes. All patients also underwent bronchoalveolar lavage.&lt;div class="boxTitle"&gt;Main Outcomes and Measures&lt;/div&gt;The primary outcome was the diagnostic yield for detecting noncaseating granulomas in patients with a final diagnosis of sarcoidosis. The diagnosis was based on final clinical judgment by the treating physician, according to all available information (including findings from initial bronchoscopy or endosonography). Secondary outcomes were the complication rate in both groups and sensitivity and specificity of bronchoalveolar lavage in the diagnosis of sarcoidosis.&lt;div class="boxTitle"&gt;Results&lt;/div&gt;A total of 149 patients were randomized to bronchoscopy and 155 to endosonography. Significantly more granulomas were detected at endosonography vs bronchoscopy (114 vs 72 patients; 74% vs 48%; P &lt; .001). Diagnostic yield to detect granulomas for endosonography was 80% (95% CI, 73%-86%); for bronchoscopy, 53% (95% CI, 45%-61%) (P &lt; .001). Two serious adverse events occurred in the bronchoscopy group and 1 in the endosonography group; all patients recovered completely. Sensitivity of the bronchoalveolar lavage for sarcoidosis based on CD4/CD8 ratio was 54% (95% CI, 46%-62%) for flow cytometry and 24% (95% CI, 16%-34%) for cytospin analysis.&lt;div class="boxTitle"&gt;Conclusion and Relevance&lt;/div&gt;Among patients with suspected stage I/II pulmonary sarcoidosis undergoing tissue confirmation, the use of endosonographic nodal aspiration compared with bronchoscopic biopsy resulted in greater diagnostic yield.&lt;div class="boxTitle"&gt;Trial Registration&lt;/div&gt;clinicaltrials.gov Identifier: NCT00872612&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">309</prism:volume>
      <prism:number xmlns:prism="prism">23</prism:number>
      <prism:startingPage xmlns:prism="prism">2457</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">2464</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/jama.2013.5823</prism:doi>
      <guid>http://jama.jamanetwork.com/article.aspx?articleID=1697962</guid>
    </item>
  </channel>
</rss>